|
Maas BiolAB relocates to Albuquerque, New Mexico ALBUQUERQUE- (BW HealthWire)-Sep. 3, 2002--Maas BiolAB, LLC has relocated its headquarters from Honolulu, Hawaii (USA) to Albuquerque, New Mexico (USA). This registered Hawaii limited liability company was formed in 1997. Maas BiolAB is a privately held Swedish-American neuropharmaceutical company. It is developing Cyclosporin Neuroprotection for traumatic brain and spinal cord injury, brain tumors, amyotrophic lateral sclerosis, Huntington's, Parkinson's and Alzheimer's diseases. Maas scientists and biotechnology partners are creating new generations of improved neuroprotectant cyclosporins, analogs and formulations. NeuroPharma AB in Lund, Sweden operates as a wholly owned subsidiary. Maas BiolAB, LLC NeuroPharma AB
|